New Crohn’s treatment option aimed at restoring immune system. Qu Biologics’ QBECO SSI is made from components of inactivated bacteria and is designed to mimic infection to activate the body’s normal immune response in the gastrointestinal tract to reverse the chronic inflammation underlying Crohn’s disease. Qu Biologics is recruiting for a Phase 1/2 clinical research trial for people living with moderate-to-severe Crohn’s disease to test QBECO SSI. The clinical trial is open to Canadian and U.S. participants. To learn more about the trial and complete an online pre-screening questionnaire to assess your eligibility, visit ow.ly/EC29g For more information, call 1.855.209.9680 or email qucrohnstrial.aa@gmail
Posted on: Sat, 13 Dec 2014 15:45:36 +0000
Trending Topics
Recently Viewed Topics
© 2015